companydata.dkReshape ApS: Financial statements 2026
CVR: 40056173
Reshape ApS (CVR 40056173) has filed annual accounts for 2026. In 2026, the company reported a gross profit of DKK 5,310,622 and a net result of DKK -42,643,506 compared with DKK -35,557,856 the year before. That is a decrease of 19.6% compared with the year before. Equity amounted to DKK 75,515,117. The solvency ratio was 86%. The company had 56 employees in the financial year.
- Gross Profit
- 5,310,622 kr.
- Profit/Loss
- -42,643,506 kr.
- Equity
- 75,515,117 kr.
- Total Assets
- 87,778,096 kr.
- Employees
- 56
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2026 | - | 5.3 mio. | -42.6 mio. | 75.5 mio. | 56 |
| 2025 | - | 6.6 mio. | -35.6 mio. | 36.6 mio. | 51 |
| 2024 | - | 1.7 mio. | -12.2 mio. | 25.1 mio. | 18 |
| 2023 | - | 2 mio. | -4.6 mio. | 26.9 mio. | 10 |
| 2022 | - | -118 t. | -1.6 mio. | 5.5 mio. | 16 |
Keep an eye on Reshape ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringAbout Reshape ApS
Reshape ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2018. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Magnus Nyborg Madsen, Daniel Storgaard and Carl-Emil Grøn Fuglesang. The company is owned by Reshape Biotech Inc.. In 2026, the company reported a gross profit of DKK 5,310,622 and a net result of DKK -42,643,506 compared with DKK -35,557,856 the year before. Equity amounted to DKK 75,515,117.